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ABSTRACT 
 
BACKGROUND The role of physical activity (PA) in treatment of childhood obesity is 
recognized. Soccer is the most played sport in Portugal.  
AIM Understand the effect of soccer practice as highly-effective treatment-program 
and evaluate its influence on obesity-related cardiometabolic comorbidities. 
SUBJECTS AND METHODS Sixty-five overweight/obese males [10(1.4)years] were 
divided in three groups: soccer (G1;n=25), individual sport-program (G2;n=20), 
control (G3;n=20). Training sessions were carried out three days-week during 6 
months by specially-trained professionals. Baseline and 6 months anthropometry, 
BMI, WtHR, body composition, blood pressure, lipid profile and HOMA IR were 
evaluated. 
RESULTS It was a severe obese sample (BMIz-sc=2.5±0.7; BFM%=35.5±7.0) with 
high cardiovascular-risk profile (WtHR=0.58±0.06; SBP=110.6±11.8%90th percentile). 
PA was associated with a decrease in BMIz-sc (G1 p=0.001; G2 p=0.000), BFM (G1 
p=0.036; G2 p=0.000), WtHR (G1 p=0.000; G2 p=0.000) and an increase in FFM (G1 
p=0.023; G2 p=0.000).  
CONCLUSION Six-month exercise-program coordinated by specially-trained 
professionals improves nutritional status, body composition, blood-pressure and lipid 
profile in severe obese children/adolescents. Soccer should be implemented as an 
innovative PA program to treat childhood obesity. 
  
INTRODUCTION 
Obesity, according to the World Health Organization (WHO), is the greatest epidemic 
disease of the XXIth century. Defined as a chronic disorder, obesity has a 
multifactorial etiology, where excess body fat has an adverse effect on health (WHO, 
2000). The worldwide exponential increase in the incidence of obesity turned it into a 
major public health problem.  
The International Obesity Task Force (IOTF) estimates that, approximately, one in 
five children is overweight and there are a total of 3 million obese children in Europe 
(Lobstein and IOTF Report for WHO, 2004).  The situation in Portugal is also of 
concerned. According to the WHO European Childhood Obesity Surveillance 
Initiative (COSI), 18.1% and 13.9% Portuguese children aged 6 to 10 are overweight 
or obese, respectively (RITO A, 2012). Portuguese Society for the Study of Obesity 
(SPEO), in a study conducted at the same time as COSI, reports almost the same 
prevalence values, transversal to the pediatric age (Galvão-Teles A, 2009). In fact, 
between 2 and 5 years, this study defends values of 29% to overweight and 12.5% to 
obesity, while in ages between 11 and 15 the values reported are 28.2% and 11.3% 
respectively. Finally, according to EPACI Portugal 2012 (unpublished data), in a 
representative sample of younger children, aged from 12 to 36 months, an off 
concerned high prevalence of overweight and obesity (31. 4% and 6. 5%, 
respectively) was observed (EPACI, 2012). 
Linked to the high prevalence, the concern has been increasing due to its association 
with cardiovascular and metabolic risk factors (CMRF) such as diabetes mellitus type 
2, systemic arterial hypertension and dislipidemia (Rêgo C, 2008). In fact, it’s well 
known the relationship between obesity and Metabolic Syndrome (MS) (Alberti KG, 
2005). MS comprises specific cardiovascular risk factors, such as central deposition 
of body fat, arterial hypertension, dyslipidemia and insulin resistance (Alberti KG, 
2005). This clustering has been shown to occur not only in adults but also in children 
and adolescents (Rêgo C, 2008; Weiss R, 2004; Zimmet P, 2007). Obesity is also 
associated with a higher risk of developing gallbladder disease, osteoarthritis, 
cancer, and mental disorders (WHO, 2000). 
Given this background, it becomes urgent to promote the awareness of the 
population regarding the emerging problem and the adoption of effective strategies in 
combating the disease. 
Physical activity (PA) is widely recognized as an essential component of obesity 
prevention (WHO, 2000). Nevertheless, it is also known that PA levels track from 
early childhood, with highest benefit (Telama R, 1997). Current literature 
demonstrates inconclusive results about the impact of PA on obesity (Sluijs E, 2007). 
Even so it was recently demonstrated that this may be due to the frequent use of 
absolute value of Body Mass Index (BMI) and not to the absence of an effective 
change in body composition (Lavelle H, 2012; George A, 2013). Furthermore, BMI 
may not be the best measure of childhood adiposity neither the best predictor of adult 
obesity (Prentice A, 2001). On the other end it’s the amount of fatness that is 
associated with cardiometabolic comorbidities and it´s already well-documented the 
efficacy of PA on modifying body composition percentages (Farias ES, 2009). In 
addition, it’s recognized the influence of PA interventions on preventing 
cardiometabolic risk in children (Meyer A, 2006).  Recently, was also suggested the 
mean of a multiple-step PA strategy in children and adolescents at risk for MS, by 
considering PA as one main tool in treatment of MS (Brambilla, 2010). It is important 
to say that the inconsistency of available data involved many limitations of the 
existent studies, namely a wide range in sample sizes and PA programs with 
different intensities, durations, frequencies and types of activities. Intervention PA 
programs for obese children are mostly based on a variety of aerobic and resistance 
activities, accommodating individual differences in PA interests (running and 
walking), and rarely link children´s interests to team-games and sport activities 
(Meyer A, 2006; Brambilla, 2010). 
 According to WHO 2010 Global Recommendations on Physical Activity for Health, 
children and youth aged 5–17 should accumulate at least 60 minutes of moderate- to 
vigorous-intensity physical activity daily. Amounts of physical activity greater than 60 
minutes provide additional health benefits and most of the daily physical activity 
should be aerobic. This document also recommends that vigorous intensity activities 
should be incorporated, including those that strengthen muscle and bone, at least 3 
times per week (WHO, 2010). However, most of the children didn’t reach these 
goals. There are some possible hypotheses trying to explain the low compliance. A 
possible explanation is linked to limited possibilities of undertaking recommended PA 
(type, duration, frequency and intensity) in many schools. Another possible 
explanation is that children perceive prescribed PA as not enjoyable because it is 
superimposed by others and not self-chosen.  Heart-rate (HR) studies demonstrate 
that children spontaneously perform only short bouts (<5 min) of activities and 
seldom participate in long sustained (>20 min) activities (Amstrong N, 1991).  
Soccer is one of the most popular, affordable, widely practiced team-sports 
worldwide. Soccer it is associated with relatively high energy expenditure and has a 
high aerobic component (HR>75 max) (Amstrong N, 1991). Recent data suggests 
that carrying out regular soccer training organized as small sided drills causes 
significant cardiovascular and muscle adaptations including muscle growth and 
elevated muscular strength (Randers MB, 2010). Soccer has been recently 
suggested as a very effective “tool” in reducing CMRF in adults (Krustrup P, 2010). 
Two recent studies analyzed the efficacy of a recreational soccer program on the 
health and fitness of overweight children (Weintraub D, 2008; Fraude O, 2010). While 
CMRF were not assessed, this data suggested that soccer had a strong positive 
effect on weight control. Given this novelty, soccer interventions may also function as 
highly effective therapeutic approach for CMRF prevention/reduction in obese 
children. 
Thus, intervention programs including soccer need to be investigated in order to 
arrive at evidence-based recommendations for its implementation on the early 
treatment of obesity and related comorbidities in childhood. 
The aims of this study are: to understand the efficacy of a systematic practice of 
recreational soccer as an innovative and highly-effective treatment program for 
adolescent obesity; to evaluate its influence on the improvement of obesity-related 
cardiometabolic comorbidities. 
 
METHODS 
This is a prospective (September 2013 to March 2014), randomized controlled trial of 
a soccer intervention program entitled “Soccer as a novel therapeutic approach to 
pediatric obesity. A randomized controlled trial and its effects on fitness, body 
composition, cardiometabolic and oxidative markers” supported by UEFA. 
 
Participants 
To be eligible for recruitment and participation, children had to be 8 to 13 years of 
age and be overweight or obese, using a body-mass index (BMI) ≥ 85th percentile for 
age and gender, according to the WHO cut-off point (Onis M, 2007). Only boys were 
recruited. Were invited all children from a school in Perafita who met the inclusion 
criteria (n=65); a total of 45 accept to participate as intervention group. From all 
children in this age-interval followed in a pediatric outpatient clinic of obesity in a 
Porto city Hospital, we have alleatory selected 20, the control group. A total of 65 
participants were included in the study.  
 
Children were excluded if they use medication or if they have any serious medical 
condition, such as, cardiovascular disease, type I diabetes, endocrine disease 
(thyroid, suprarenal) as also hepatic disease. Participation in structured exercise or 
weight loss programs in the last year was also considered exclusion criteria.  
 
The study was carried out in accordance with the Declaration of Helsinki (2000).  
Ethical approval was obtained from the Faculty of Sport of Porto Ethics Committee. 
All Children and their parents were fully informed about the study participation and 
given their written informed consent. The study staff was trained prior to the data 
assessments, and was guaranteed a total respect and privacy to the participants 
involved.  
 
Study design and training interventions 
After completing the baseline measures according to a study protocol, children from 
Perafita school were randomly assigned to two different training groups [G1: soccer 
program (n=25); G2: individual sport program (n=20)]. Training sessions for both 
groups were carried out three days per week (Monday, Wednesday, Friday, 18:00-
19:30 hour) and were conducted by professors from the Faculty of Sport of Porto 
University. The “soccer program” consisted of a warm-up (10min), different technical 
exercises and small-sided games (40-50min) and a cool-down (10min). The 
“individual sport program” included a warm-up (10-20min), different kind of activities 
such as walking, running, and exercises to improve coordination and strength (40-
50min) and a cool-down (10min).  
The control group (G3) (n=20) comprised children whose physical activities were 
limited to those included in the compulsory physical education curriculum (2 sessions 
per week, 45-90 minutes each). 
 
Study Protocol 
All evaluations were taken at baseline (before randomization) and after 6 months 
(post-intervention), using the same standardized protocol. A study protocol was used 
from whom, for this study, we have analyzed the following variables: 
 
Anthropometric and nutritional status characterization  
The assessment of all anthropometric values followed both methodology and 
techniques internationally recommended (Jelliffe DB, 1989). All measures were made 
with every child/adolescent being barefoot and on underwear. 
 
Weight evaluation was obtained using the InBody® 230 device 0.1kg precision and 
the results obtained were expressed in kilograms. To obtain the standing-height 
values, a fixed stadiometer (Holtain Ltd.) with 0.1cm precision was used and the 
results were expressed in meters.  
Body-mass index (BMI) was directly calculated by the InBody® 230 software. It was 
expressed in kilograms per square meter. To define excess weight and obesity it was 
assumed a z-score value equal or higher than 1.0364 (which is equivalent 85th 
percentile) and equal or higher than 1.6449 (which is equivalent to 95th percentile).  
The z-score values of all anthropometric variables were calculated using the WHO 
AnthroPlus® software (WHO anthro).  
 
To evaluate waist circumference (WC) a 150cm flexible measuring tape (Holtain, 
Lda) with 0.1cm precision was used and the measurement was performed on bare 
skin at the umbilical scar level. The results are expressed in centimetres. These 
values together with height in centimetres allowed the establishment of the ratio 
between waist circumference and height (WtHR). The cut-off used to represent 
cardiovascular risk was 0.500 (McCarthy HD, 2006). 
 
Body composition  
Body composition was assessed by direct segmental multi-frequency bioelectrical 
impedance using InBody® 230 device, able to predict fat mass excess in a way 
similar to DEXA (203). The values obtained were expressed in percentage for fat 
mass (%BFM, 0.1% precision) and in kilograms for muscle mass (MM, 0.1kg 
precision). Percentage of FFM (%FFM) was calculated using both values of muscle 
mass and weight in kilograms.  
 
Biological Maturity status 
Stage of pubic hair (PH) was the indicator of biological maturity status. Stage of PH 
based on the criteria of Tanner (1982) was evaluated at clinical examination by a 
pediatrician experienced in the assessment of secondary sex characteristics (Tanner 
J, 1962). It was stratified as Tanner 1:  prepubertal, Tanner 2 and 3: medium puberty 
and Tanner 4 and 5: final puberty. 
 
Blood pressure 
Resting blood pressure (BP) evaluation was determined in a comfortable and quiet 
room, by oscilometric method and using a Philips® VM6 device with a 0.1mmHg 
precision. The measurement was made according to international recommendations 
(National Heart, Lung and Blood Institute, 2004). The cuff was correctly chosen for 
each participant. We registered three measures with an interval of 2-3 minutes and 
the lower one was the final value. Systolic (SBP) and diastolic (DBP) values obtained 
were expressed in millimetres of mercury. According to international 
recommendations, “normal BP” is deﬁned as SBP and DBP less than 90th percentile 
for age, sex and height, whereas “hypertension” is deﬁned for values persistently 
equal or above the 95th percentile, measured on at least three separate occasions. 
Children with SBP or DBP equal or greater than 90th but less than 95th percentile 
are classiﬁed as having “high-normal BP”. Adolescents with BP 120/80 mmHg or 
more even if less than 90th percentile are also considered as having “high-normal 
BP”. 
 
Biochemistry 
After an overnight fast, between 8.00 and 10.00 a.m., blood samples were collected 
by venipuncture in EDTA containing tubes and processed within 2 hours of collection, 
from all participants at baseline and after six months. Aliquots of plasma were made 
and stored at -80oC until assayed. Analysis of baseline and follow up samples were 
performed in the same day. 
Blood samples were analyzed for total cholesterol (TC), high-density lipoprotein-
cholesterol (HDL-c), triglycerides (TG), glucose (G) and plasma insulin. TC and TG 
concentrations were determined by enzymatic colorimetric tests (CHOD-PAP and 
GPO-PAP methods, Roche, respectively). HDL-c was measured using a specific 
enzymatic colorimetric test (Direct HDL cholesterol, Roche). Low-density lipoprotein-
cholesterol (LDL-c) concentration was calculated using Friedewald formula 
(Friedewald, 1972). The determination of circulating levels of glucose and insulin was 
performed by using routine automated technology (Roche). 
The following scores were defined based on the level of cardiovascular risk: Score 1 
- without risk [TC < 170 mg/dl; TG < 90 mg/dl; LDL-c < 110 mg/dl; HDL-c > 45 mg/dl]; 
Score 2 - average risk [TC≥ 170 <200 mg/dl; TG≥ 90 <130 mg/dl; LDL- c ≥ 110 <130 
mg/dl; HDL-c ≥40 ≤45 mg/dl]; Score 3 - high risk [TC ≥ 200 mg/dl; TG ≥ 130 mg/dl; 
LDL-c ≥ 130 mg/dl; HDL-c < 40 mg/dl]. Score 3 corresponds to the 95th percentile 
score for TC, TG and LDL-c and the 5th percentile for the HDL-c (National Heart, 
Lung and Blood Institute, 2011).  
The degree of insulin resistance was estimated with the use of the homeostatic 
model assessment for insulin resistance (HOMA-IR) and calculated as the product of 
the fasting plasma insulin (µU/ml) and the fasting plasma glucose (mg/dl) divided by 
405 (Matthews DR, 1985).  Insulin-resistance was defined for HOMA-IR values equal 
or greater than 2.67 and 5.22 for pre- and pubertal adolescents, respectively 
(Kurtoğlu, 2010).  
Statistical analyses  
Descriptive statistics (means and standard deviations) were calculated for both 
groups at the baseline and at the conclusion of the study. None of the 
anthropometric, body composition and cardiometabolic risk factors measures showed 
significant deviations from a normal distribution (Kolmogorov-Smirnov normality test). 
Baseline differences in mean anthropometric and body composition characteristics 
between groups were tested with one-way analysis of variance (ANOVA). The 
intervention effects were evaluated with repeated measures ANOVA. The 
significance level in all analyses was set at 0.05. Statistical analyses were conducted 
using SPSS version 21.0. 
 
RESULTS 
In the present study, 65 children and adolescents aged 8-13 years old (mean age of 
10.6±1.2 years) were enrolled. All of them are males and more than half of them are 
classified as at medium-phase of puberty (Tanner stage 2-3= 56.2%) (Table I).From 
all sample, 63 (97 %) have completed baseline and 6-month measurements, the two 
drop-out belonging to both exercise-groups (G1 and G2). Children with only one 
measurement (either baseline or post-intervention) did not differ from the remaining 
in terms of outcome variables (data not shown).  
The anthropometric and body composition characteristics at baseline and after 6 
months are shown in Table I. No statistical differences between groups were 
observed at baseline (p>0.05). However, after 6 months intervention, exercise-
groups G1 and G2 showed a significant improvement in BMI z-score, WC and WtHR 
compared to G3-control group. In addition, BFM and FFM percentages were 
respectively significantly lower and greater after the intervention in both exercise-
groups (G1 and G2), in contrast with a significant increase in the percentage of BFM 
(p=0.005) and no changes in FFM (p=0.032) observed in G3-control group (Table I). 
Regarding blood-pressure, no statistical differences between groups were observed 
at baseline (p>0.05). Beside this, the medium value for SBP for all groups, at 
baseline and after 6 months, is greater than the 90th percentiles, which define an “at 
risk” population (Table I). With the exception of DBP in G1, changes in SBP and DBP 
after the intervention period did not differ between groups at 6 months (Table I). 
In Table II we can observe the WHtR behaviour. In fact, only in both exercise-groups 
G1 and G2 we find a decrease in the number of children and adolescents with an at-
risk WHtR, after 6 months intervention.   
Characterization of the lipid profile, glucose and insulin metabolism as also insulin 
resistance (HOMA-IR) was summarized in Table III. The medium value for studied 
lipid profile variables were between normal ranges, when considered all sample. 
After intervention (T1), whereas TC and LDL-c decreased only in the G1 and TG 
decreased only in the G2, HDL-c increased in both groups. No significant changes 
were observed in G3.  HOMA-IR was between normal range for the studied 
population and no significant changes were observed in intervention groups. 
As DBP expressed as % 90th percentile show a mean value between normal ranges 
(Table I), we consider only SBP for the stratification of all sample according to risk-
score for BP. On Table 4 we can observe a considerable decrease in the prevalence 
of High-BP after intervention on both PA groups, G1 and G2.  
On Table 5 we can observe lipid profile variables grouped according to the score of 
risk. Only exercise groups G1 and G2 show a decrease prevalence of risk-score 3 
after intervention, with significant differences for TC (p=0.002) and LDL-c (p= 0.001) 
for G1 and TG (p= 0.008) and HDL-c (p= 0.033) for G2. No differences in the 
prevalence of at-risk HOMA IR values were observed after intervention in all groups.   
 
DISCUSSION 
Obesity is now widely accepted as a multifactorial disease where diet and physical 
activity play an essential key-role, not only in prevention, but also in treatment. 
A sedentary lifestyle affected by urbanization as well the increasing lack of motivation 
to participate in organized physical activity that occur through childhood and 
adolescence, are some of the factors who can justify the great difficulty to meet the 
recommendations concerning PA practice in pediatric ages (Santaliestra, 2013). The 
synergism between lower performance and easy fatigability observed in obese 
children/adolescents increases this difficulty and results in a decreased motivation to 
participate in any physical activity program, or even in any sports-team.   
Taking into account these considerations, if the aim is the promotion of PA in 
pediatric age, especially in those with overweight/obesity, it is crucial to find an 
enjoyable and popular sport. The involvement with pleasure and fun, increases 
motivation and self-esteem and acts as a guarantee of success. Soccer, as 
previously referred, is one of the most popular team-sports in Portugal, reason that 
supports their choice for an intervention program with Portuguese obese children and 
adolescents, named “Soccer as a novel therapeutic approach to pediatric obesity”. 
This project, supported by UEFA Research Grant Programme Application (ref 
NASP/jud, 16 May 2013), is a controlled trial, with 6-month follow-up, were the 
practice of recreational soccer as a new and highly-effective treatment program for 
childhood obesity was encouraged. In fact, we want to analyze the influence of 
exercise, in particular soccer practice, on the improvement of nutritional status, body-
composition as also obesity-related cardiometabolic comorbidities. Because in our 
country soccer is most frequently played by boys, we have decided, in this first study, 
only to select males. 
For that, 45 school-children between 8-13 years (mean: 10.6 y) previously diagnosed 
as overweight/obese, were randomly incorporated in two different groups [G1: soccer 
program (n=25); G2: individual sport program (n=20)]. A group of overweight/obese 
patients followed in an outpatient clinic of obesity in a Porto city Hospital were 
enrolled for the control group (G3: n=20). An equal nutrition intervention was 
developed for the three groups at baseline.  
A great magnitude of obesity can be observed at baseline (BMI z-sc= 2.53 ± 0.7; 
BFM %= 35.5±7.0), with no differences between groups (Table I). The literature is not 
consensual regarding the effect of PA on nutritional status (Jovanović R, 2010), being 
one of the major reason for the lack of consensus the variability of measures used by 
different authors (WHO, 1995). In fact, different method creates some difficulty to 
analyze the results, as some of them have different interpretations. Usually, and 
given its simplicity, BMI is the most frequent measured used as it is accepted as a 
universal method for assessing nutritional status as also adiposity in children and 
adolescents (Cornier MA, 2011). Even so, if we consider that calculation of BMI takes 
into account two index with a highly variability in the pediatric age (height and 
weight), the use of absolute BMI, as seen in the mostly previous data, decrease its 
sensibility. On the other side, the use of BMI z-sc for age and sex increases 
sensibility. In our sample, we had a significant reduction in obesity levels for both 
exercise groups and an increase in control group (BMI z-sc: T0=2.5(0.9) and 
T1=2.7(0.9) (Table I). Despite the significant decrease of BMI z-sc in G1 and G2, 
children`s maintains an obese status (BMI z-sc = 2.2±0.5 and 2.3 ±0.8 respectively) 
(Table I).  It’s also well known the limitation of BMI as a measure of body composition 
as it reflects both fat and fat-free components of body weight (Prentice A, 2001). It is 
acceptable that PA could increase lean muscle mass and decrease fat component 
with no overall change or even with an earlier increase in BMI. In fact, even BMI is 
easier to evaluate, body composition rather than body weight or body-mass, might be 
more appropriate as more accurate. In our population we can observe that physical 
activity was significantly associated with de decrease in BFM as also intra-abdominal 
deposition of fat (WC) and an increase of FFM (Table I). In accordance with previous 
data our study  have shown the effects of PA on body composition suggesting that a 
reduction in adiposity can occur while maintaining or even increasing FFM in children 
(Farias ES, 2009; Lazzer S, 2008). The treatment of obese children should aim a 
decrease in FFM, instead of lost FFM. In order to ensure the adequate growth and 
development, and, at same time, prevent cyclic weight regain. Notably, a decrease in 
FFM can result in subsequent reduction in basal metabolic rate, which then becomes 
a major risk factor for weight gain (Wong PC, 2008). Regarding that, we consider that 
the use of BMI z-score instead absolute BMI, as also the use of the high-sensitive 
InBody ® to characterize body compositions are two of the strengths of our study. 
Recent studies defend also the use of indexes such as WC and WtHR as highly 
sensitive and specific markers of upper body fat accumulation in children (McCarthy 
HD, 2001; McCarthy HD, 2006). WC measurements could offer a more sensitive 
means than BMI for identifying overweight and obese children who might be at an 
increased risk for developing metabolic complications (McCarthy HD, 2001). Even 
so, it’s difficult to precise the influence of height in WC (McCarthy HD, 2001). WtHR 
takes height into account and has been proposed as an indicator of the excessive 
amount of upper body fat comprising several health risks (McCarthy HD, 2006). A 
WtHR cutt-off point was already established for adults (higher than >0,500) (Ashwell 
MA, 1996) and recent data propose the use of the same value for children (McCarthy 
HD, 2006). Beside that recent proposition regarding the use of the adult cut-off point 
in pediatric age, this has not yet validated in children and in fact it might over-
estimate the number of children considered at-risk. In our study, the medium value 
for WtHR for all sample is greater than 0.500 (Table I) and with almost all 
overweight/obese boys showing a value greater than 0.500 at baseline (Table II), 
which should be a cause for concern as define this population as at high-risk of 
cardiometabolic comorbidities.  We can observe a positive influence of PA on WC 
(Table I) and WtHR (Tables I and II), but without differences between the exercise-
groups G1 and G2 (Table II). Anyhow, the both groups, when compared to control 
group, demonstrated a significant effect on module these two central-adiposity 
markers as G3 show no changes, after 6 months follow-up (Tables I and II) . Even 
knowing that decrease of central adiposity is more slowly and difficult than total 
adiposity, the decrease of WC and WtHR verified in present data demonstrate that 
exercise of moderate-high intensity is associated with significantly reduction on this 
markers and contribute for lowering the risk to develop cardiovascular comorbidities 
and acute coronary events later in life (Miller, 2005). In addition, we consider the use 
of the WtHR instead the measure of the waist alone, is one more strength of our 
study. 
Furthermore, the strong positive relationship between BMI and BP in children and the 
association between BMI z-score values higher than 1.0 (matching 85th percentile) 
with the expression of elevated blood pressure values are supported by literature 
(Falkner B, 2006; Guimarães IC, 2008). In fact, increase in pediatric hypertension 
growth in parallel with increasing prevalence of pediatric obesity worldwide (Muntner 
P, 2004). Otherwise, it seems that expression of high-blood pressure as a 
consequence of obesity needs time, being the adolescence-age associated with 
duplication in hypertension prevalence (Rêgo C, 2008). Our obese population (mean 
BMI z-score 2.5), with a mean age of 10.6 years and almost all of them at Tanner 
stage 2-3, shows a mean value for SBP greater than the 90th percentile at baseline 
(Table I), which indicates a high-risk to become hypertensive adults (Lurbe E, 2009 ; 
Bao W, 1995). Hypertension associated with pediatric obesity is usually a systolic-
hypertension, and that fact is well documented in our population as mean value for 
DPB at baseline is lower than 90th percentile (Table I). According to our data, it is not 
possible to proof that PA (either G1 or G2) has an influence on SBP when compared 
to control group (G3) or when we compare the two intervention groups alone (G1 vs 
G2). The absence of improvement in SBP may be due to the short time of 
intervention. However, when we stratify the population in each intervention-group 
according to the classification in “Normal”, “Normal-High” or “High” BP, we can 
observe, in both exercise groups (G1 and G2), a tendency toward a decrease in the 
prevalence of high SBP that was not observed in G3 (Table IV). Finally, only the G1 
had a significant improvement on DBP values (Table I).  
However, PA is well recognized as tool in the prevention and treatment of high blood 
pressure in adults, including the obese population (Hagberg JM, 2000). In 
accordance, the effects of PA have been also benefic in the overweight children or 
adolescents (Torrance B, 2007). A recent study provides further evidence to support 
a causal relationship between higher levels of PA and lower DBP (Knowles G, 2013). 
Although this effect might look small (2 mm Hg lower DBP), this reduction in BP at 
adult-age is associated with a 6% reduction in CHD and 15% reduction in stroke-
related events (Cook NR, 1995). With this knowledge, we support that PA and 
particularly soccer could be efficient tools in BP maintenance, and consequently in 
the prevention of complicated diseases, even in obesity children. 
Cardiovascular risk is associated with obesity dyslipidemia, characterized by lower 
levels of HDL-c concomitantly with an increase in TC, TG and LDL-c (Miller WM, 
2005). A strong stability in the risk of lipid profile in pediatric age could predict the 
adult’s levels, even considering the variability of lipid profile during child development 
(Rêgo C, 2008). Obesity, even at pediatric age, is associated with increased risk of 
an atherogenic lipid profile (Horri M, 2006; Rêgo C, 2008).However, and on contrary 
of blood-pressure behavior, it seems that genetic predisposition is more important on 
the clinical expression of the disease than age or duration of obesity (Rêgo C, 2008). 
In our study we did not investigate family history of cardiovascular disease and this 
may be a weakness of our work. Regarding our results, we observe that our 
extremely obese children`s and adolescents shows a lipid profile at baseline with 
medium values between normal ranges, what means that can be classified as a “no 
risk” population (Table III).However, important improvements in lipid profile were 
observed after intervention in both exercise-groups G1 and G2 with no changes from 
baseline to 6 months follow-up on G3 control-group (Table III).Current 
recommendations about cardiovascular risk centered their concern on LDL-c levels, 
showing that a reduction on it level decreases the risk of cardiovascular events and 
lowered mortality (Institute, 2011). On our study, only soccer training was responsible 
for a significant decrease in LDL-c, as no changes were observe in G2 and G3 
control-group (Table III). However, when we stratify our sample according to score 
of-risk of each variable, soccer showed a higher effect in reduce the prevalence of all 
CMRF with score 3, classified as “high risk”, when compared to G2 and G3 (Table 
V).  One possible explanation for that it’s the fact that soccer training were 
predominantly aerobic, the muscle metabolism more strongly associated with 
improvement on lipid profile (Randers B, 2010). In addition, objective differences 
reflecting the influence of PA on Insulin Resistance (IR) weren’t reported in our study. 
However, the fact that we have an early-aged population associated with the 
predominant absence in IR at baseline probably explains the lack of effect (Table V). 
At last it is important to state that our study supports the growing evidence of the 
benefits of PA (soccer program and individual sport program) in reducing BMI and 
improve body-composition, as also lipid profile and blood-pressure, in 
overweight/obese children`s and adolescents. We do not find significant differences 
between soccer and individual sport program (G1 vs G2). As we mentioned, all PA 
classes were given to G1 and G2 by teachers from Sports faculty who are strongly 
engaged with children’s and works hard to improve motivation in order to increase 
the success of intervention program. Taking into account that “Enjoy and have 
pleasure. Feel good. Be motivated. Work hard” are the main propose of both 
exercise-groups (G1 and G2), probably the great commitment of all teachers can 
explain the lack of differences between exercise-groups (Tables I, II, III). 
CONCLUSION 
Soccer training, as also individual sport program, maintained during 6 months, was 
associated with significant decrease in BMI z-score, central adiposity (WC and 
WtHR) and body fat-mass, concomitantly with an increase on FFM, in a severe 
obese pediatric population. Significant changes were also observed regarding lipid 
profile in association to PA, whereas only SBP in soccer group show an improvement 
after 6 months intervention. A reduction in the prevalence of “High” SBP and an at-
risk score for lipid profile were observed in both exercise groups. 
The healthy-related improvements observed in both exercise groups as also the 
small number of “drop-outs” may be explained by the fact that all PA classes were 
coordinated by a high-motivated professional. 
As a pilot study, the current study was carried out in a small sample of children and 
adolescents and only dated 6 months, which hampered the finding of statistical 
significant differences. Longer studies, with greater samples and using the same 
methods are needed, to reinforce these results. 
However, our results help us to reinforce the importance of physical activity in the 
promotion of healthy lifestyle as also in prevention and treatment of childhood 
obesity. In addition, results from this study encourage us to guide future researches 
around soccer as an innovative and potential type of successful PA proposal for 
obese children`s and adolescents. 
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Table I. Characterization of the sample at baseline (TO) and after 6 months 
intervention (T1), according to intervention group: nutritional status [m (dp)], 
body composition [m (dp)], blood pressure [m (dp)] and Tanner Stage [n (%)]. 
 
 
 
All 
Sample 
 
G1 
 
G2 
 
 
G3 
 
T0 T0 T1 p 
 
T0 
 
T1 p T0 T1 P 
 
CA 
(years) 
10.3 
(1.4) 
10.5 
(1.5) 
10.9 
(1.6) 
0.000 
10.7 
(1.2) 
11.3 
(1.1) 
0.000 
9.7 
(1.3) 
10.3 
(1.3) 
0.000 
Height 
(z-score) 
1.0 
(1.1) 
 
1.1 
(1.1) 
0.8 
(1.0) 
0.030 
0.6 
(0.7) 
0.5 
(0.7) 
0.136 
1.2 
(1.3) 
1.0 
(1.3) 
0.239 
BMI 
(z-score) 
 
2.5 
(0.7) 
 
2.4 
(0.5) 
2.2 
(0.5) 
 0.001 
2.5 
(0.8) 
2.3 
(0.8) 
0.000 
2.5 
(0.9) 
2.7 
(0.9) 
0.145 
WC 
(90th  
percentile) 
 
88,9 
(10.6) 
 
82.7 
(9.7) 
80.0 
(9.5) 
0.001 
90.2 
(9.4) 
85.2 
(8.2) 
0.000 
85.8 
(12.1) 
85.5 
(12.3) 
0.740 
WtHR 
 
0.58 
(0.06) 
 
0.56 
(0.4) 
0.54 
(0.04) 
0.000 
0.61 
(0.06) 
0.57 
(0.06) 
0.000 
0.59 
(0.06) 
0.58 
(0.07) 
0.196 
BFM 
(%) 
35.5 
(7.0) 
34.2 
(5.6) 
32.3 
(5.5) 
  0.036 
 
38.3 
(7.8) 
 
34.2 
(10.1) 
0.000 
34.4 
(7.6) 
37.5 
(10.5) 
0.005 
FFM 
(%) 
 
34.7 
(7.2) 
34.4 
(7.6) 
35.6 
(8.0) 
  0.023 
34.3 
(6.8) 
36.9 
(7.6) 
0.000 
35.5 
(7.3) 
34.9 
(6.9) 
0.332 
SBP 
(%90th 
percentile) 
 
110.6 
(11.8) 
110.3 
(12.4) 
113 
(12.0) 
   0.292 
110.5 
(7.0) 
114.7 
(11.8) 
0.151 
111.3 
(15.3) 
110.5 
(8.9) 
0.782 
DBP 
(% 90th 
percentile) 
 
56,8 
(9.0) 
57,4 
(8.8) 
54 
(7.7) 
0.014 
56,7 
(.,2) 
52,9 
(7.7) 
0.1530 
56 
(10.6) 
56,7 
(6.2) 
0.799 
Tanner 
Stage 
[n(%)] 
    T1 23(40.4) 
  T2-3 31(54.4) 
    T4-5 3(5.3) 
 
        
      T1 12(50) 
 T2-3 11(48.8) 
    T4-5 1(4.2) 
 
 
 
   T1 8(33.3) 
T2-3 15(62.5) 
  T4-5 1(4.2) 
 
 
 
0.082 
 
 
 
   T1 3(18.8) 
T2-3 11(68.8) 
   T4-5 2(12) 
 T1 2(12.5) 
 T2-3 11(68.8) 
  T4-5-3(18.2) 
 
0.112 
 
 
   T1 8(47.1) 
   T2-3 9(53) 
    T4-5 0(0) 
   T1 5(29.4) 
T2-3 12(70.6) 
   T4-5 0(0) 
 
0.083 
 
 
 
G1: soccer program; G2: individual sport program; G3: control group 
CA: Chronological Age; BMI: Body Mass Indez; WC: waist circumference; WtHR: waist to Height 
Ratio; BMF: Body Fat Mass; FFM: Fat-Free Mass; SBP: Systolic Blood Pressure; DBP: Diastolic Blood 
Pressure   
 
 
Table II WHtR risk of cardiometabolic comorbidity: characterization of the 
sample at baseline (TO) and after 6 months intervention (T1), according to 
intervention group [n (%)]. 
 
All Sample 
 
G1 
 
G2 
 
G3 
 
 
T0 T0 T1    T0     T1 T0 T1 
WHtR < 0.500 1(1.8 ) 0(0) 4(17.4) 0(0) 3(17.6) 1(5.9) 1(6.3) 
WHtR ≥ 0.500 56(98.2) 23(100) 19(82.6) (17)100 14(82.4) 16(94.1) 15(93.8) 
 
G1: soccer program; G2: individual sport program; G3: control group 
WHtR < 0.500: without cardiometabolic risk; WHtR ≥ 0.500: high cardiometabolic risk 
  
Table III Lipid profile (mg/dl), glucose (mg/dl), insulin (µU/mL) and insulin 
resistance (HOMA-IR): characterization of all sample and according to 
intervention group at baseline (TO) and after 6 months intervention (T=1) 
[m(dp)]. 
 
All 
sample 
 
 
G1 
 
 
G2 
 
 
G3 
 
 
 T0 T0 T1 p T0 T1 P T0 T1 P 
TC  
 
166.9 
(36.5) 
174.2 
(45.3) 
163.39 
(32.8) 
0.023 
156.6 
(28.4) 
150.2 
(25.7) 
0.264 
166.1 
(23.6) 
176.7 
(25.8) 
0.110 
 
TG  
 
76.4 
(43.6) 
70.8 
(33.4) 
54.61 
(16.6) 
0.062 
93.8 
(60.7) 
64.1 
(28.8) 
0.007 
64.3 
(29.8) 
77.3 
(50.7) 
0.282 
LDL-c 
100.6 
(34.9) 
105.6 
(44.6) 
92.8 
(33.8) 
0.007 
89.3 
(23.6) 
84.2 
(26.1) 
0.353 
105.5 
(22.7) 
109.9 
(28.5) 
0.490 
HDL-c  
51.1 
(11.2) 
54.4 
(9.2) 
59.6 
(11.7) 
0.003 
48.5 
(14.7) 
53.2 
(13.4) 
0.025 
47.7 
(8.2) 
51.3 
(9.8) 
0.137 
Glucose 
82.9 
(5.8) 
80.7 
(4.9) 
84.67 
(9.84) 
0.030 
85.5 
(4.5) 
89.7 
(7.3) 
0.059 
84.0 
(7.5) 
83.7 
(5.6) 
0.893 
 
Insulin  
 
 
9.1 
(4.4) 
8.4 
(3.4) 
8.06 
(3.21) 
0.794 
10.4 
(6.3) 
9.5 
(3.9) 
0.568 
8.7 
(2.8) 
10.9 
(3.3) 
0.225 
HOMA-
IR 
1.9 
(1.0) 
1.7 
(0.7) 
1.72 
(0.82) 
0.903 
2.2 
(1.4) 
2.1 
(0.9) 
0.782 
1.8 
(0.6) 
2.2 
(0.7) 
0.284 
 
G1: soccer program; G2: individual sport program; G3: control group 
TC: Total Cholesterol; TG: Triglycerides; LDL-c: Low density lipoprotein cholesterol; HDL-c: High 
Density lipoprotein cholesterol 
 
 
  
Table IV. Systolic Blood Pressure (SBP): characterization of the sample at 
baseline (TO) and after 6 months intervention (T1), according to intervention 
group. [n (%)] 
 
 
All Sample 
 
 
G1 
 
 
G2 
 
 
G3 
 
 T0 T0 T1    T0            T1 T0 T1 
Normal 
SBP 
 
31 
(59.6) 
 
14 
(58.3) 
 
21 
(87.5) 
6 
(46.2) 
11 
(84,6) 
11 
(73.3) 
13 
(86.7) 
Normal-
High 
SBP 
 
4 
(7.7) 
2 
(8.3) 
 
1 
(4.2) 
1 
(7.7) 
0 
( 0) 
1 
(6.7) 
0 
(0) 
High 
SBP 
 
17 
(32.7) 
8 
(33.3) 
2 
(8.3) 
6 
(46.2) 
2 
(15.4) 
3 
(20.0) 
2 
(13.3) 
 
G1: soccer program; G2: individual sport program; G3: control group 
Normal BP: < 90
th
 percentile; Normal-high BP: ≥ 90
th
 percentile < 95
th
 percentile; High BP: ≥ 95
th (25)
 
 
 
 
 
 
 
 
 
 
 
 Table V. Prevalence of each CMRF according to score of risk of all sample and 
according to intervention group at baseline (TO) and after 6 months 
intervention (T=1). . [n(%)] 
 
 
 
All sample 
 
 
G1 G2 G3 
 T0 T0 T1 p T0 T1 P T0 T1 p 
TC 
Score 1 
Score 2 
Score 3 
 
30 (62.5) 
11 (22.9) 
7 (14.6) 
13 (59.1) 
4 (18.2) 
5 (22.7) 
15 (68.2) 
4 (18.2) 
3 (13.6) 
0.002 
10 (71.4) 
3 (21.4) 
1 (7.1) 
12 (85.7) 
1 (7.1) 
1 (7.1) 
0.233 
7 (58.3) 
4 (33.3) 
1 (8.3) 
5 (41.7) 
5 (50) 
1 (8.3) 
0.002 
TG 
Score 1 
Score 2 
Score 3 
 
40 (83,3) 
3 (6.3) 
5 (10,4) 
18 (81.8) 
2 (9.1) 
2 (9.1) 
21 (95.5) 
1 (4.5) 
0 (0) 
0.227 
11 (78.6) 
1 (7.1) 
2 (14.3) 
13 (92.9) 
0 (0) 
1 (7.1) 
0.018 
11 (91.7) 
0 (0) 
1 (8.3) 
9 (75) 
2 (16.7) 
1 (8.3) 
0.264 
LDL-c 
Score 1 
Score 2 
Score 3 
 
34 (70,8) 
8 (16,7) 
6 (12,5) 
16 (72.7) 
1 (4.5) 
5 (22.7) 
19 (86.4) 
0 (0) 
3 (13.6) 
0.001 
11 (78.6) 
3 (21.9) 
0 (0) 
13 (92.9) 
0 (0) 
1 (7.1) 
0.588 
7 (58.3) 
4 (33.3) 
1 (8.3) 
6 (50) 
4 (33.3) 
2 (16.7) 
0.001 
HDL-c 
Score 1 
Score 2 
Score 3 
 
35 (72.9) 
5 (10.4) 
8 (10.7) 
18(81.8) 
1 (4.5) 
3 (13.6) 
16 (86.4) 
1 (4.5) 
2 (9.1) 
0.277 
9 (64.3) 
1 (7.1) 
4 (28.6) 
8 (57.1) 
4 (28.6) 
2 (14.3) 
0.033 
8 (66.7) 
3 (25) 
1(8.3) 
9 (75) 
2 (16.7) 
1(8.3) 
0.046 
IR 
No 
yes 
 
 
46 (96.0) 
2 (4.0) 
 
 
22 (100) 
0 (0) 
 
 
22 (100) 
0 (0) 
 
- 
13 (92.9) 
1 (7.1) 
13 (92.9) 
1 (7.1) 
0.773 
 
12 (100) 
0 (0) 
 
 
12 (100) 
0 (0) 
 
- 
 
G1: soccer program; G2: individual sport program; G3: control group 
TC:Total Cholesterol;  HDL-c: High-Density Lipoprotein cholesterol; LDL-c: Low-Density Lipoprotein cholesterol;  TG: 
Triglycerides; IR: Insulin-resistance defined according to HOMA-IR values 23 
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All submissions should be made online at Annals of Human Biology’s ScholarOne Manuscripts site. 
New users should first create an account. Once a user is logged onto the site, submissions should be 
made via the Author Centre. If you experience any problems with your submission or with the site, 
please contact ScholarOne support through the „get help now‟ link. 
 
All submissions must include full disclosure of all relationships that could be viewed as presenting a 
potential conflict of interest. If there are no conflicts of interest, authors should state that there are 
none. This must be stated at the point of submission (within the manuscript, after the main text under 
a subheading "Declaration of interest", and, within the appropriate field on the journal's ScholarOne 
Manuscripts site). 
 
Please see our full Declaration of Interest Policy for further information. 
 
Authors are required to provide the names of at least three potential reviewers who are not 
collaborators. 
 
Article Types Considered by Annals of Human Biology 
 
 Research Papers 
 Review Articles 
 Short Reports 
 Human Biological Surveys 
 Book Reviews 
Manuscript Preparation 
File preparation and types 
 
Authors should prepare manuscripts according to Council of Science Editors (CSE) Scientific Style 
and Format (7th edition) and are also referred to recent copies of the Journal and encouraged to copy 
the published format of papers therein. Microsoft Word format (.doc or .docx files) is preferred. 
Documents must be typed in 12pt font, double-spaced, with margins of at least 2.5 cm on all sides. 
Tables and figures should not appear in the main text, but should be submitted as separate digital 
files and designated with the appropriate file type on ScholarOne Manuscripts. Manuscripts must be 
submitted in grammatically correct English. Manuscripts which do not meet this standard cannot be 
reviewed and will be returned to the author. References should be given in Harvard style (see 
References section for example). 
Authors should prepare and upload two versions of their manuscript. One should be a complete text, 
while in the second all document information identifying the author should be removed from files to 
allow them to be sent anonymously to referees. When uploading files authors will then be able to 
define the non-anonymous version as "File not for review". Manuscripts should be compiled in the 
following order: title page; abstract; main text; acknowledgments; Declaration of Interest statement; 
appendices (as appropriate); references; tables with captions (on separate pages); figures; figure 
captions (as a list). 
Title Page 
 
A title page should be provided comprising the manuscript title plus the full names, affiliations and 
email addresses of all authors involved in the preparation of the manuscript. One author should be 
clearly designated as the corresponding author and full contact information, including phone number, 
provided for this person. Three to five key terms that are not in the title should also be included on the 
title page. These keywords will assist indexers in cross indexing your article. 
Abstract 
 
Authors submitting papers should note that structured abstracts (up to 200 words) are required. 
These should outline the questions investigated, the design, essential findings and main conclusions 
of the study under the following sub-headings: Background, Aim, Subjects and methods, Results, 
Conclusion. 
For review articles, abstracts should be structured as follows: Context, Objective, Methods (including 
data sources, study selection and data extraction), Results and Conclusion. They should be written in 
an informative style permitting their use, without revision, by abstracting services, give essential 
details of research findings without further reference to the text, and avoid generalisations and 
nonessential information. 
Structured abstracts are not required for Short Reports. 
 
Main Text 
 
The main text should, in general, but not necessarily, be divided into sections with the headings: 
Introduction, Methods, Results, Discussion, Conclusion.  
 
Research Papers 
Research papers, which must report original research, will typically be between 5000 and 8000 
words, debating and exploring theoretical and methodological issues, methodological approaches, 
and original studies relevant to human biology. However, there is not necessarily an upper limit on 
length. Authors of longer papers are encouraged to contact the Editors with a synopsis. 
 
Review Articles 
The body of a review article should be a comprehensive, scholarly evidence-based review of the 
literature, accompanied by critical analysis and leading to reasonable conclusions. Wherever possible 
details of the literature search methodology should be provided, i.e. the databases searched (normally 
Medline and at least one or two other databases), the search terms and inclusive dates, and any 
selectivity criteria imposed. 
Review articles or essays are generally commissioned by invitation of the Editors but authors are 
invited to contact the Editors with proposals. 
 
Short Reports 
Short reports will normally be on topics of more restricted breadth than research papers, including 
papers which would be regarded as including essentially preliminary findings. Typically, they should 
have a maximum of approximately 1500 words, have no more than two tables or figures, and a 
maximum of around fifteen references. Short reports generally follow the same format as full papers, 
except that a structured abstract is not required. 
 
 
 
Human Biological Surveys 
Human biological surveys describe surveys of the morphological, genetic and biodemographic 
characteristics of a sample. Such investigations are not usually hypothesis driven but rather seek to 
record the biological structure (physical status) of the sample at a particular moment in time. Such 
surveys would include those carried out with the aim of investigating, for example, secular trends in 
somatic and developmental characteristics, nutritional surveys of specific groups, morphological and 
genetic surveys, and biodemographic information on migration and marriage structure. Please click 
here  for further information, including preparation guidelines. 
 
Book Reviews 
Book reviews are by invitation. 
Acknowledgments and Declaration of Interest Statement 
 
Acknowledgments and Declaration of interest sections are different, and each has a specific purpose. 
 
The Acknowledgments section details special thanks, personal assistance, and dedications. 
Contributions from individuals who do not qualify for authorship should also be acknowledged here. 
 
Declarations of interest, however, refer to statements of financial support and/or statements of 
potential conflict of interest. Within this section also belongs disclosure of scientific writing assistance 
(use of an agency or agency/ freelance writer), grant support and numbers, and statements of 
employment, if applicable. For a more detailed list of points to include, please see “Declaration of 
Interest section” below. 
Acknowledgments section 
Any acknowledgments authors wish to make should be included in a separate headed section at the 
end of the manuscript preceding any appendices, and before the references section. Please do not 
incorporate acknowledgments into notes or biographical notes. 
 
Declaration of Interest section 
All declarations of interest must be outlined under the subheading „Declaration of interest‟. If authors 
have no declarations of interest to report, this must be explicitly stated. The suggested, but not 
mandatory, wording in such an instance is: The authors report no declarations of interest.  When 
submitting a paper via ScholarOne Manuscripts, the „Declaration of interest‟ field is compulsory 
(authors must either state the disclosures or report that there are none). If this section is left empty 
authors will not be able to progress with the submission. 
 
Please see our full Declaration of Interest Policy for further information. 
 
Please note: grant number(s) of NIH/Wellcome Trust-funded papers must be included in the 
Declaration of Interest statement. 
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References should be given in the Harvard style. Citation in the text is by author and date (Smith 
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Periodical titles should be abbreviated and conform to the style given by Index Medicus. 
 
Tables and figures 
 
Tables and figures should be referred to in text as follows: Figure 1, Figure 2; Table I, Table II. The 
place at which a table or figure is to be inserted in the printed text should be indicated clearly on a 
manuscript. Each table and/or figure must have a legend that explains its purpose without reference 
to the text.  
 
Tables should be used only when they can present information more efficiently than running text. 
Care should be taken to avoid any arrangement that unduly increases the depth of a table, and the 
column heads should be made as brief as possible, using abbreviations liberally. Lines of data should 
not be numbered nor run numbers given unless those numbers are needed for reference in the text. 
Columns should not contain only one or two entries, nor should the same entry be repeated 
numerous times consecutively. Tables should be grouped at the end of the manuscript on separate 
pages. 
 
Figures/Illustrations (line drawings, halftones, photos, photomicrographs, etc.) should be submitted as 
digital files for highest quality reproduction and should follow these guidelines: 
 
 300 dpi or higher 
 Sized to fit on journal page 
 EPS, JPG, TIFF, or PSD format only 
 Submitted as separate files, not embedded in the text 
 Legends or captions for figures should be listed on a separate page, double spaced 
 
For information on submitting animations, movie files and sound files or any additional information 
including indexes and calendars please click here. 
 
For information on colour figures and charges please click here 
 
Notes on Style 
 
General Style 
Authors are asked to take into account the diverse audience of the journal. Please avoid the use of 
terms that might be meaningful only to a local or national audience, or provide a clear explanation 
where this is unavoidable. Some specific points on style follow: 
 
1. Authors should write in clear, concise English. If this is not your native language please ensure 
the manuscript has been reviewed by a native speaker. Please note: extensive rewriting of the 
text will not be undertaken by the editorial staff. 
2. Acronyms for protein and gene names should in all cases be explained the first time they 
appear. In articles where acronyms are numerous, authors should include a table that lists all 
acronyms, each acronym‟s meaning or origin, and a short description of the function of each 
gene or protein. 
3. Latin terminology, including microbiological and species nomenclature, should be italicized. 
4. Use standard convention for human and animal genes and proteins: italics for genes and 
regular font for proteins, and upper case for human products and lower case for animal 
products. 
5. “US” is preferred to “American”, “USA” to “United States”, and “UK” to “United Kingdom”. 
6. Double quotation marks rather than single are to be used unless the “quotation is „within‟ 
another”. 
7. Punctuation of common abbreviations should adhere to the following conventions: “e.g.”; “i.e.”; 
“cf.”. Note that such abbreviations should not generally be followed by a comma or a (double) 
point/period. 
8. Upper case characters in headings and references should be used sparingly, e.g. only the first 
word of paper titles, subheadings and any proper nouns begin upper case; similarly for the titles 
of papers from journals in the references and elsewhere. 
9. Apostrophes should be used sparingly. Thus, decades should be referred to as follows: “The 
1980s [not the 1980‟s] saw …”. Possessives associated with acronyms (e.g. APU), should be 
written as follows: “The APU‟s findings that …” but note that the plural is “APUs”. 
10. All acronyms for national agencies, examinations, etc., should be spelled out the first time they 
are introduced in text or references. Thereafter the acronym can be used if appropriate, e.g. 
“The work of the Assessment of Performance Unit (APU) in the early 1980s …” and 
subsequently, “The APU studies of achievement …”, in a reference “(Department of Education 
and Science [DES] 1989a)”. 
11. Brief biographical details of significant national figures should be outlined in the text unless it is 
quite clear that the person concerned would be known internationally. Some suggested editorial 
comments in a typical text are indicated in the following with square brackets: “From the time of 
H. E. Armstrong [in the 19th century] to the curriculum development work associated with the 
Nuffield Foundation [in the 1960s], there has been a shift from constructivism to heurism in the 
design of [British] science courses”. 
12. Non-discriminatory language is mandatory. Sexist or racist terms should not be used. 
13. The referred local (national) usage for ethnic and other minorities should be used in all papers. 
For the USA, “African-American”, “Hispanic” and “Native American” are used, e.g. “The African-
American presidential candidate, Jesse Jackson …”; for the UK, “Afro-Caribbean” (not “West 
Indian”), etc. 
14. Material to be emphasised by italicisation in the printed version should be italicised in the 
typescript rather than underlined. Please use such emphasis sparingly. 
15. Numbers in text should take the following forms: 300, 3000, 30 000 (not 30,000). Spell out 
numbers under 10 unless used with a unit of measure, e.g. nine pupils but 9 mm (do not use 
full stops (periods) within units). For decimals, use the form 0.05 (not .05, × 05 or 0× 05). “%” 
(not “per cent”) should be used in typescripts. 
16. Authors must adhere to SI Units 
17. Appendices should appear before the references section and after any acknowledgments 
section. The style of the title is shown by the following example: 
“Appendix C: The random network generator”. 
Figures and tables within appendices should continue the sequence of numbering from the 
main body of the text. Sections within appendices should be numbered, for example, C.1, C.2. 
Equations in appendices should be numbered, for example, (C 1), (C 2). If there is only one 
appendix, it is referred to as “the appendix” and not called “Appendix A”. 
 
Abbreviations and nomenclature 
For abbreviations and nomenclature, authors should consult the most recent edition of the CSE Style 
Manual available from the Council of Science Editors, 60 Revue Drive, Suite 500 Northbrook, IL, 
60062, USA. 
 
Mathematics 
Please click here for more information on the presentation of mathematical text. 
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current address information for an author (if different from that shown in the affiliation). Information 
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end of the paper. Acknowledgments of the assistance of colleagues or similar notes of appreciation 
belong in a separate Acknowledgments section. 
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